199 related articles for article (PubMed ID: 10798759)
1. An interleukin-2-IgG-Fas ligand fusion protein suppresses delayed-type hypersensitivity in mice by triggering apoptosis in activated T cells as a novel strategy for immunosuppression.
Bulfone-Paus S; Rückert R; Krause H; von Bernuth H; Notter M; Pohl T; Tran TH; Paus R; Kunzendorf U
Transplantation; 2000 Apr; 69(7):1386-91. PubMed ID: 10798759
[TBL] [Abstract][Full Text] [Related]
2. Suppression of the cell-mediated immune response by a Fas-immunoglobulin fusion protein.
Shen Y; Young B; Lipman ML
Transplantation; 2006 Apr; 81(7):1041-8. PubMed ID: 16612282
[TBL] [Abstract][Full Text] [Related]
3. An IgG3-IL2 fusion protein activates complement, binds Fc gamma RI, generates LAK activity and shows enhanced binding to the high affinity IL-2R.
Harvill ET; Morrison SL
Immunotechnology; 1995 Aug; 1(2):95-105. PubMed ID: 9373338
[TBL] [Abstract][Full Text] [Related]
4. [Blocking the escape of leukemic cells from killing of T cell by combining anti-Fas ribozyme and CD80-IgG fusion protein].
Liu LB; Li WM; He W; Zhang M; Xiao J; Zhong ZD; Li L; Zou P
Zhonghua Yi Xue Za Zhi; 2005 Dec; 85(49):3469-74. PubMed ID: 16686062
[TBL] [Abstract][Full Text] [Related]
5. The Nef-mediated AIDS-like disease of CD4C/human immunodeficiency virus transgenic mice is associated with increased Fas/FasL expression on T cells and T-cell death but is not prevented in Fas-, FasL-, tumor necrosis factor receptor 1-, or interleukin-1beta-converting enzyme-deficient or Bcl2-expressing transgenic mice.
Priceputu E; Rodrigue I; Chrobak P; Poudrier J; Mak TW; Hanna Z; Hu C; Kay DG; Jolicoeur P
J Virol; 2005 May; 79(10):6377-91. PubMed ID: 15858021
[TBL] [Abstract][Full Text] [Related]
6. Negative regulation of CD95 ligand gene expression by vitamin D3 in T lymphocytes.
Cippitelli M; Fionda C; Di Bona D; Di Rosa F; Lupo A; Piccoli M; Frati L; Santoni A
J Immunol; 2002 Feb; 168(3):1154-66. PubMed ID: 11801650
[TBL] [Abstract][Full Text] [Related]
7. Two adjacent trimeric Fas ligands are required for Fas signaling and formation of a death-inducing signaling complex.
Holler N; Tardivel A; Kovacsovics-Bankowski M; Hertig S; Gaide O; Martinon F; Tinel A; Deperthes D; Calderara S; Schulthess T; Engel J; Schneider P; Tschopp J
Mol Cell Biol; 2003 Feb; 23(4):1428-40. PubMed ID: 12556501
[TBL] [Abstract][Full Text] [Related]
8. Fas ligand-expressing B-1a lymphocytes mediate CD4(+)-T-cell apoptosis during schistosomal infection: induction by interleukin 4 (IL-4) and IL-10.
Lundy SK; Boros DL
Infect Immun; 2002 Feb; 70(2):812-9. PubMed ID: 11796615
[TBL] [Abstract][Full Text] [Related]
9. Enhancement of susceptibility to Fas-mediated apoptosis of TH1 cells by nonmitogenic anti-CD3epsilon F(ab')2.
Yu XZ; Anasetti C
Transplantation; 2000 Jan; 69(1):104-12. PubMed ID: 10653388
[TBL] [Abstract][Full Text] [Related]
10. Fas and activation-induced Fas ligand mediate apoptosis of T cell hybridomas: inhibition of Fas ligand expression by retinoic acid and glucocorticoids.
Yang Y; Merćep M; Ware CF; Ashwell JD
J Exp Med; 1995 May; 181(5):1673-82. PubMed ID: 7536793
[TBL] [Abstract][Full Text] [Related]
11. IL-2-IgG2b fusion protein suppresses murine contact hypersensitivity in vivo.
Rückert R; Brandt K; Hofmann U; Bulfone-Paus S; Paus R
J Invest Dermatol; 2002 Aug; 119(2):370-6. PubMed ID: 12190859
[TBL] [Abstract][Full Text] [Related]
12. IL-2 induces Fas ligand/Fas (CD95L/CD95) cytotoxicity in CD8+ and CD4+ T lymphocyte clones.
Esser MT; Dinglasan RD; Krishnamurthy B; Gullo CA; Graham MB; Braciale VL
J Immunol; 1997 Jun; 158(12):5612-8. PubMed ID: 9190908
[TBL] [Abstract][Full Text] [Related]
13. Regulation of T cell activation in vitro and in vivo by targeting the OX40-OX40 ligand interaction: amelioration of ongoing inflammatory bowel disease with an OX40-IgG fusion protein, but not with an OX40 ligand-IgG fusion protein.
Higgins LM; McDonald SA; Whittle N; Crockett N; Shields JG; MacDonald TT
J Immunol; 1999 Jan; 162(1):486-93. PubMed ID: 9886424
[TBL] [Abstract][Full Text] [Related]
14. B cells engineered to express Fas ligand suppress pre-sensitized antigen-specific T cell responses in vivo.
Kosiewicz MM; Krishnan A; Worthington MT; Matriano JA; Ross WG
Eur J Immunol; 2002 Jun; 32(6):1679-87. PubMed ID: 12115651
[TBL] [Abstract][Full Text] [Related]
15. Interleukin-6 (IL-6) prevents activation-induced cell death: IL-2-independent inhibition of Fas/fasL expression and cell death.
Ayroldi E; Zollo O; Cannarile L; D' Adamio F; Grohmann U; Delfino DV; Riccardi C
Blood; 1998 Dec; 92(11):4212-9. PubMed ID: 9834226
[TBL] [Abstract][Full Text] [Related]
16. Possible role of organ-specific autoantigen for Fas ligand-mediated activation-induced cell death in murine Sjögren's syndrome.
Ishimaru N; Yanagi K; Ogawa K; Suda T; Saito I; Hayashi Y
J Immunol; 2001 Nov; 167(10):6031-7. PubMed ID: 11698484
[TBL] [Abstract][Full Text] [Related]
17. Mature but not immature Fas ligand (CD95L)-transduced human monocyte-derived dendritic cells are protected from Fas-mediated apoptosis and can be used as killer APC.
Hoves S; Krause SW; Halbritter D; Zhang HG; Mountz JD; Schölmerich J; Fleck M
J Immunol; 2003 Jun; 170(11):5406-13. PubMed ID: 12759415
[TBL] [Abstract][Full Text] [Related]
18. Nonlymphoid Fas ligand in peptide-induced peripheral lymphocyte deletion.
Pinkoski MJ; Droin NM; Lin T; Genestier L; Ferguson TA; Green DR
Proc Natl Acad Sci U S A; 2002 Dec; 99(25):16174-9. PubMed ID: 12454289
[TBL] [Abstract][Full Text] [Related]
19. Down-regulation of normal human T cell blast activation: roles of APO2L/TRAIL, FasL, and c- FLIP, Bim, or Bcl-x isoform expression.
Bosque A; Pardo J; Martínez-Lorenzo MJ; Iturralde M; Marzo I; Piñeiro A; Alava MA; Naval J; Anel A
J Leukoc Biol; 2005 Apr; 77(4):568-78. PubMed ID: 15653751
[TBL] [Abstract][Full Text] [Related]
20. Fas ligand-mediated cytotoxicity is directly responsible for apoptosis of normal CD4+ T cells responding to a bacterial superantigen.
Ettinger R; Panka DJ; Wang JK; Stanger BZ; Ju ST; Marshak-Rothstein A
J Immunol; 1995 May; 154(9):4302-8. PubMed ID: 7536768
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]